CureVac Welcomes Axel Sven Malkomes as New Chief Financial Officer
Malkomes joins CureVac at a pivotal moment as the company enters a new chapter of growth and innovation, bringing over three decades of senior corporate and investment banking experience within the biotech and pharmaceutical industries.
Life Sciences | 05/11/2024 | By Aishwarya
Roche Inaugurates Pharma Research and Development Center in Basel
Roche has launched its new Pharma Research and Early Development (pRED) Center at its global headquarters in Basel, Switzerland.
Life Sciences | 11/09/2024 | By Aishwarya | 100
Zydus Gets Tentative Approval from USFDA for Azilsartan Medoxomil Tablets
Zydus Lifesciences Ltd. has secured a tentative approval from the United States Food and Drug Administration (USFDA) to market Azilsartan Medoxomil Tablets, 40 mg and 80 mg (USRLD: Edarbi tablets).
Life Sciences | 06/07/2024 | By Aishwarya | 200
Tobin Scientific Announces Acquisition of BioRepository Resources
Tobin Scientific has acquired BioRepository Resources LLC (BRR), a leader in biological sample storage and management solutions, located in New Providence, New Jersey.
Life Sciences | 03/07/2024 | By Aishwarya | 166
Vector Laboratories and Absolute Biotech Announce Merger to Enhance Life Sciences Offerings
This strategic move aims to solidify Vector Laboratories' position as a comprehensive supplier of custom-engineered and catalog antibodies, sophisticated bioconjugation linkers, and expertise in bioconjugation.
Life Sciences | 20/05/2024 | By Abha | 196
Porvair Sciences displays examine units and microplates for Cancer Research
Porvair Sciences will display its measure packs and microplates for malignant growth and life science research at the American Association for Cancer Research (AACR) meeting in New Orleans, USA from the eighth - thirteenth April 2022.
Life Sciences | 16/04/2022 | By Sudeep Soparkar | 542
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy